Sign in to continue:

Wednesday, January 28th, 2026

Memiontec Holdings Ltd. Receives Listing and Quotation Notice for Rights Cum Warrants Issue

Memiontec Holdings Ltd. Secures Listing Approval for Upcoming Rights Cum Warrants Issue

Key Points: 1, 2
Memiontec Holdings Ltd. has received the listing and quotation notice (LQN) from the Singapore Exchange Securities Trading Limited (SGX-ST) for the upcoming Rights cum Warrants Issue.
The LQN covers the listing and quotation of up to 440,514,000 Rights Shares, up to 704,822,400 Warrants, and up to 704,822,400 New Shares arising from the exercise of the Warrants.
The Rights cum Warrants Issue is subject to shareholders’ approval at the Extraordinary General Meeting (EGM) and compliance with SGX-ST’s listing requirements.
Potential Price-Sensitive Information:
The successful completion of the Rights cum Warrants Issue, subject to shareholders’ approval, could be a significant event that may impact the company’s share price.
The issuance of up to 440,514,000 Rights Shares and 704,822,400 Warrants, if fully subscribed, could result in a significant increase in the company’s share capital and potential future dilution for existing shareholders.
The exercise of the Warrants and the issuance of up to 704,822,400 New Shares could also have a dilutive effect on the company’s share price and shareholding structure.
Conclusion: The receipt of the LQN from the SGX-ST for Memiontec Holdings Ltd.’s upcoming Rights cum Warrants Issue is a significant milestone for the company. The successful completion of this corporate action, subject to shareholders’ approval, could have a substantial impact on the company’s share price and capital structure. Investors should closely monitor the developments surrounding the Rights cum Warrants Issue and consider the potential risks and opportunities it may present.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with financial advisors before making any investment decisions. The author and the publication are not responsible for any investment decisions made based on the information provided.

View Memiontec Hldgs Historical chart here



Frencken Group Reports 6.5% Revenue Growth in 3Q25 Driven by Mechatronics Division and Strong Semiconductor Performance

Frencken Group Limited 3Q25 Business Update: Key Highlights and Investor Insights Frencken Group Limited 3Q25 Business Update: Strong Revenue Growth Amid Ongoing Economic Uncertainties Key Financial Highlights for Investors Revenue Growth: Frencken Group Limited...

iX Biopharma Partners with Orion to Accelerate WaferiX® Commercialisation in US Market via FDA-Licensed Compounding Network

iX Biopharma Secures Strategic U.S. Partnership to Accelerate WaferiX® Commercialisation iX Biopharma Secures Strategic U.S. Partnership to Accelerate WaferiX® Commercialisation Key Highlights Transformational milestone: iX Biopharma is transitioning from an R&D-focused company to a...

Singapore Paincare Holdings Announces Extension of Trading Halt Until 4 December 2025

Singapore Paincare Holdings Limited: Extension of Trading Halt – What Investors Need to Know Singapore Paincare Holdings Limited: Extension of Trading Halt – Key Details for Investors Summary of Key Points Trading Halt Extension:...